Anti-infective compounds

Disclosed are imidazo[1,2-a]pyridine-3-carboxamide compounds of the general formula 1a, wherein the variables are defined herein, and the use thereof in the treatment of bacterial infections, such as tuberculosis. In one embodiment the compound is 6-chloro-N-((2-cyclohexylbenzo[d]oxazol-5-yl)methyl)...

Full description

Saved in:
Bibliographic Details
Main Authors JEON HEEKYOUNG, CECHETTO JONATHAN, KIM JAESEUNG, KIM YOUNG MI, KANG SUNHEE, NO ZAESUNG, FENISTEIN DENIS PHILIPPE CEDRIC, LEE SAEYEON, EWANN FANNY ANNE, GENOVESIO AUGUSTE, JI YOUN NAM, SEO MIN JUNG, JAMUNG HEO, CHRISTOPHE THIERRY, BRODIN PRISCILLE, JIYEON JANG
Format Patent
LanguageEnglish
Published 29.08.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are imidazo[1,2-a]pyridine-3-carboxamide compounds of the general formula 1a, wherein the variables are defined herein, and the use thereof in the treatment of bacterial infections, such as tuberculosis. In one embodiment the compound is 6-chloro-N-((2-cyclohexylbenzo[d]oxazol-5-yl)methyl)-2-ethylimidazo[1,2-a]pyridine-3-carboxamide.
Bibliography:Application Number: NZ20110602311